Registry of Patients Treated With Systemic Mold-Active Triazoles

Status Completed

Clinical Trial Summary

The purpose of this study is to describe representative real-world patterns of care for the management of invasive fungal infections (IFIs), including invasive mold infection (IMI). Specifically, the study goals are to examine real world patient characteristics and treatment patterns, associated healthcare resource utilization, and outcomes associated with use of mold-active triazoles (MATs) to treat invasive fungal infections (IFIs).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03066011
Study type	Observational
Source	Astellas Pharma Inc
Contact
Status	Completed
Phase
Start date	March 16, 2017
Completion date	April 24, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01888458` - Antifungal Prophylaxis With Micafungin After Cord Blood Allogeneic Stem Cell Transplantation (MycaCOORD)	Phase 2
Completed	`NCT00412893` - Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis	Phase 3
Completed	`NCT04004078` - An Individualized Administration Research of Voriconazole Based on CYP2C19 Gene Polymorphism and TDM
Completed	`NCT01576653` - Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL	N/A
Enrolling by invitation	`NCT02510053` - Pharmacokinetics and Pharmacodynamics of Caspofungin (Cancidas ®) and Drug Tolerance of Fungi to Patients With an Invasive Fungal Infection in the Intensive Care Unit	N/A
Completed	`NCT01198236` - Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal Infection	Phase 4
Recruiting	`NCT06137690` - Factors on Therapeutic Drug Monitoring and Safety of Voriconazole in Critically Ill Elderly Patients
Completed	`NCT01783379` - Pharmacokinetics of Micafungin in Patients Intensive Care Unit
Completed	`NCT01533558` - Pharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates
Recruiting	`NCT03149562` - Association of Plasma Transfusions and Invasive Fungal Infection
Recruiting	`NCT04665037` - Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)	Phase 2
Withdrawn	`NCT01185405` - Voriconazole Plasma Level in Intensive Care Unit (ICU) Patients	N/A
Terminated	`NCT01148160` - Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy	N/A
Completed	`NCT00893555` - Pharmacologic Optimization of Voriconazole	Phase 3
Unknown status	`NCT00460330` - Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCT	N/A
Completed	`NCT02823132` - Study of the Level of a Protein Which Could Predict the Development of a Fungal Infection in Patients With Acute Leukemia	N/A